Ghent University Academic Bibliography

Advanced

Essentials for selecting antimicrobial therapy for intra-abdominal infections

Stijn Blot UGent, Jan De Waele UGent and Dirk Vogelaers UGent (2012) DRUGS. 72(6). p.e17-e32
abstract
Intra-abdominal infection (IAI) is a complex disease entity in which different aspects must be balanced in order to select the proper antimicrobial regimen and determine duration of therapy. A current classification indicates different faces of peritonitis. Primary peritonitis implies an intact gastrointestinal tract without overt barrier disruption. Secondary peritonitis refers to localized or diffuse peritoneal inflammation and abscess formation due to disruption of the anatomical barrier. Tertiary peritonitis includes cases that cannot be solved by a single or even sequential surgical intervention, often in combination with sequential courses of antimicrobial therapy. The most frequently used classification distinguishes 'uncomplicated' and 'complicated' IAI. In uncomplicated IAI, the infectious process is contained within a single organ, without anatomical disruption. In complicated IAI, disease is extended, with either localized or generalized peritonitis. However, there exists more than a single dimension of complexity in IAI, including severity of disease expression through systemic inflammation. As the currently used classifications of IAI often incite confusion by mixing elements of anatomical barrier disruption, severity of disease expression and (the likelihood of) resistance involvement, we propose an alternative for the current widely accepted classification. We suggest abandoning the terms 'uncomplicated' and 'complicated' IAI, as they merely confuse the issue. Furthermore, the term 'tertiary peritonitis' should likewise be discarded, as this simply refers to treatment failure of secondary peritonitis resulting in a state of persistent infection and/or inflammation. Hence, anatomical disruption and disease severity should be separated into different phenotypes for the same disease in combination with either presence or absence of risk factors for involvement of pathogens that are not routinely covered in first-line antimicrobial regimens (Pseudomonas aeruginosa, enterococci, Candida species and resistant pathogens). Generally, these risk factors can be brought back to recent exposure to antimicrobial agents and substantial length of stay in healthcare settings (5-7 days). As such, we developed a grid based on the different components of the classification: (i) anatomical disruption; (ii) severity of disease expression; and (iii) either community-acquired/early-onset healthcare-associated origin or healthcare-associated origin and/or recent antimicrobial exposure. The grid allows physicians to define the index case of IAI in a more unequivocal way and to select the most convenient empirical antimicrobial regimens. The grid advises on the necessity of covering nosocomial Gram-negative bacteria (including P. aeruginosa), enterococci and yeasts. The basis of antimicrobial therapy for IAI is that both Gram-negative and anaerobic bacteria should always be covered. In recent years, some newer agents such as doripenem, moxifloxacin and tigecycline have been added to the antimicrobial armamentarium for IAI. For patients in whom the source can be adequately controlled, antimicrobial therapy should be restricted to a short course (e.g. 3-7 days in peritonitis).
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
SECONDARY BACTERIAL PERITONITIS, INTENSIVE-CARE-UNIT, MULTIDRUG-RESISTANT BACTERIA, BETA-LACTAM ANTIBIOTICS, CRITICALLY-ILL PATIENTS, POSTOPERATIVE PERITONITIS, ESCHERICHIA-COLI, RISK-FACTORS, INVASIVE CANDIDIASIS, ABDOMINAL SEPSIS
journal title
DRUGS
Drugs
volume
72
issue
6
pages
e17 - e32
Web of Science type
Article
Web of Science id
000304132700009
JCR category
TOXICOLOGY
JCR impact factor
4.633 (2012)
JCR rank
7/85 (2012)
JCR quartile
1 (2012)
ISSN
0012-6667
DOI
10.2165/11599800-000000000-00000
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
2120826
handle
http://hdl.handle.net/1854/LU-2120826
date created
2012-05-30 10:28:08
date last changed
2013-07-08 13:45:38
@article{2120826,
  abstract     = {Intra-abdominal infection (IAI) is a complex disease entity in which different aspects must be balanced in order to select the proper antimicrobial regimen and determine duration of therapy. A current classification indicates different faces of peritonitis. Primary peritonitis implies an intact gastrointestinal tract without overt barrier disruption. Secondary peritonitis refers to localized or diffuse peritoneal inflammation and abscess formation due to disruption of the anatomical barrier. Tertiary peritonitis includes cases that cannot be solved by a single or even sequential surgical intervention, often in combination with sequential courses of antimicrobial therapy. The most frequently used classification distinguishes 'uncomplicated' and 'complicated' IAI. In uncomplicated IAI, the infectious process is contained within a single organ, without anatomical disruption. In complicated IAI, disease is extended, with either localized or generalized peritonitis. However, there exists more than a single dimension of complexity in IAI, including severity of disease expression through systemic inflammation. As the currently used classifications of IAI often incite confusion by mixing elements of anatomical barrier disruption, severity of disease expression and (the likelihood of) resistance involvement, we propose an alternative for the current widely accepted classification. We suggest abandoning the terms 'uncomplicated' and 'complicated' IAI, as they merely confuse the issue. Furthermore, the term 'tertiary peritonitis' should likewise be discarded, as this simply refers to treatment failure of secondary peritonitis resulting in a state of persistent infection and/or inflammation. Hence, anatomical disruption and disease severity should be separated into different phenotypes for the same disease in combination with either presence or absence of risk factors for involvement of pathogens that are not routinely covered in first-line antimicrobial regimens (Pseudomonas aeruginosa, enterococci, Candida species and resistant pathogens). Generally, these risk factors can be brought back to recent exposure to antimicrobial agents and substantial length of stay in healthcare settings (5-7 days). As such, we developed a grid based on the different components of the classification: (i) anatomical disruption; (ii) severity of disease expression; and (iii) either community-acquired/early-onset healthcare-associated origin or healthcare-associated origin and/or recent antimicrobial exposure. The grid allows physicians to define the index case of IAI in a more unequivocal way and to select the most convenient empirical antimicrobial regimens. The grid advises on the necessity of covering nosocomial Gram-negative bacteria (including P. aeruginosa), enterococci and yeasts. The basis of antimicrobial therapy for IAI is that both Gram-negative and anaerobic bacteria should always be covered. 
In recent years, some newer agents such as doripenem, moxifloxacin and tigecycline have been added to the antimicrobial armamentarium for IAI. For patients in whom the source can be adequately controlled, antimicrobial therapy should be restricted to a short course (e.g. 3-7 days in peritonitis).},
  author       = {Blot, Stijn and De Waele, Jan and Vogelaers, Dirk},
  issn         = {0012-6667},
  journal      = {DRUGS},
  keyword      = {SECONDARY BACTERIAL PERITONITIS,INTENSIVE-CARE-UNIT,MULTIDRUG-RESISTANT BACTERIA,BETA-LACTAM ANTIBIOTICS,CRITICALLY-ILL PATIENTS,POSTOPERATIVE PERITONITIS,ESCHERICHIA-COLI,RISK-FACTORS,INVASIVE CANDIDIASIS,ABDOMINAL SEPSIS},
  language     = {eng},
  number       = {6},
  pages        = {e17--e32},
  title        = {Essentials for selecting antimicrobial therapy for intra-abdominal infections},
  url          = {http://dx.doi.org/10.2165/11599800-000000000-00000},
  volume       = {72},
  year         = {2012},
}

Chicago
Blot, Stijn, Jan De Waele, and Dirk Vogelaers. 2012. “Essentials for Selecting Antimicrobial Therapy for Intra-abdominal Infections.” Drugs 72 (6): e17–e32.
APA
Blot, S., De Waele, J., & Vogelaers, D. (2012). Essentials for selecting antimicrobial therapy for intra-abdominal infections. DRUGS, 72(6), e17–e32.
Vancouver
1.
Blot S, De Waele J, Vogelaers D. Essentials for selecting antimicrobial therapy for intra-abdominal infections. DRUGS. 2012;72(6):e17–e32.
MLA
Blot, Stijn, Jan De Waele, and Dirk Vogelaers. “Essentials for Selecting Antimicrobial Therapy for Intra-abdominal Infections.” DRUGS 72.6 (2012): e17–e32. Print.